II. Epidemiology
- Unintended Pregnancy accounts for 43% of the approximately 5.3 Million pregnancies per year in U.S.
 - Elective pregnancy termination varies by year in U.S. by is roughly 600,000 per year
 - Costs in U.S (2020)
- Vaginal Delivery costs $15,000
 - Cesarean Section costs $29,000
 
 
III. Risk Factors: Unintended Pregnancy
- Difficult access to Contraception
- No Contraception or inconsistent Contraception accounts for 95% of unintended pregnancies
 
 - Age 20-24 years old
 - Less social support
 - Unmarried
 - Income below poverty line
- Women ages 15 to 44 years old with incomes below poverty line (RR 5)
 
 - Non-hispanic Black
 - Major Depression symptoms
 - Emotional stress
 - Childhood Sexual Assault
 - Intimate Partner Violence
 - Decreased social support
 
IV. Evaluation
- See Pregnancy Dating
 
V. Management: Counseling
- Approach
- Offer assistance in non-judgemental manner
 
 - Counseling regarding options
- Carry fetus to delivery and raise the child
- Offer to connect the mother to social services and public health resources
 
 - Carry fetus to delivery and offer child for adoption (less commonly chosen in U.S.)
 - Elective pregnancy termination
- Medical providers may conscientiously refuse to perform certain procedures if not consistent with their principles
 - However, in these cases AAFP and ACOG recommend providers offer safe referrals for these services
 
 
 - Carry fetus to delivery and raise the child
 
VI. Management: Elective Termination
- 
                          General
- Guttmacher Institute Summary of Elective Termination laws
 
 - Safety
- First trimester termination does not appear to increase risk of Ectopic Pregnancy, preterm birth or Miscarriage
 - Legal pregnancy termination appears safe (mortality 0.6 per 100,000 live births compared with 8.8 per 100,000)
 - Contrast with unsafe abortion practices when legal abortion services are not available
- Highly toxic chemicals have been used (e.g. Chloroquine, detergents, kerosene, turpentine)
 - Foreign body insertion and intentional abdominal or back Trauma may also result in serious complications
 - Haddad (2009) Rev Obstet Gynecol 2(2):122-6 +PMID: 19609407 [PubMed]
 
 - No longterm psychological impact from elective termination
 - Clostridial Toxic Shock Syndrome
- Associated with vaginal Misoprostol protocols without Antibiotic prophylaxis (regimens before 2006)
 - Rare now with newer regimens that use oral or buccal Misoprostol and Antibiotic prophylaxis
 - Fjerstad (2009) N Engl J Med 361(2): 145-51 +PMID:19587339 [PubMed]
 
 - Pregnancy termination may fail in some cases
- If this occurs, pregnancy care should continue with a high risk obstetrician (e.g. maternal fetal medicine)
 
 
 - First Trimester regimens (<77 days gestation)
- Mifrepristone 200 mg and Misoprostol 800 mcg (preferred)
 - Other medication options include Methotrexate/Misoprostol and Misoprostol alone
- However, combined Mifepristone and Misoprostol is preferred for its effectiveness in 98% of cases
 - Misoprostol 800 mcg orally alone has an efficacy of 85 to 95% in Termination of Pregnancy
 - Zhang (2022) Cochrane Database Syst Rev (5): CD002855 [PubMed]
 
 - Surgical Methods
- Vacuum aspiration
 - Dilation and Curettage
 
 
 - Second-Trimester regimens
- Medical induction (admit for delivery)
- Efficacy and safety
- Success rate: 91%
 - Retained Placenta in 21% of cases
 
 - Primary protocol
- Mifrepristone 200 mg and Misoprostol 400 mcg
- Start: Mifrepristone 200 mg orally
 - Next: Misoprostol 400 mcg sublingual, buccal starting in 24-48 hours, every 3 hours for up to 5 doses
 
 - Misoprostol alone
- 400 mcg vaginal or sublingual every 3 hours for up to 5 doses
 
 
 - Mifrepristone 200 mg and Misoprostol 400 mcg
 - Other medications
 
 - Efficacy and safety
 - Surgical Methods (preferred)
- Efficacy and Safety
- Overall preferred by patients over medical induction
 - Faster than medical induction
 - Lower complication rate than medical induction (4%)
- Cervical Laceration
 - Uterine perforation
 
 
 - Procedures
- Dilation and Evacuation
 
 
 - Efficacy and Safety
 
 - Medical induction (admit for delivery)
 - Additional measures
- RhoGAM (if Rh Negative)
 - Obstetric Ultrasound
- Typically used to confirm Early Pregnancy Loss and assess Gestational Age
 - Also obtain for risk of Ectopic Pregnancy (e.g. Adnexal Mass, PID history, IUD pregnancy, Adnexal Mass)
 - Ultrasound is not needed in regular Menses, LMP within 56 days and no Ectopic Pregnancy risks or symptoms
 - Ultrasound may be required by local law before Termination of Pregnancy
 
 - Quantitative bhCG
- Obtained to monitor serially to confirm completed Miscarriage
 
 
 
VII. Management: Self-Medicated Termination of Pregnancy
- Background
- In the U.S. since 2018, there has been a significant decrease in access to services for Termination of Pregnancy
- This has resulted in an increase in self-medicated Termination of Pregnancy (unsupervised)
 
 - National resources have developed to assist patients self-medicated termination
- Examples include Plan C, Mayday Health, Miscarriage and Abortion Hotline
 - Most commonly used agent for self-Medication is Misoprostol (Cytotec) alone
 
 
 - In the U.S. since 2018, there has been a significant decrease in access to services for Termination of Pregnancy
 - Confirmation of completion
- Resolution of Pregnancy Symptoms (e.g. Breast fullness, Nausea)
 - Qualitative and Quantitative hCG tests may be positive for up to 4 to 6 weeks after abortion (EAB or SAB)
- Serial Quantitative hCG (48 to 72 hours apart) may be useful in establishing a trend
 
 - Consider pelvic Ultrasound (esp. if intrauterine pregnancy has not been confirmed)
 
 - Protocol for patients reporting bleeding and other symptoms after self-medicated termination
- Background
- Heavier bleeding and passage of clots is more common after termination at >=10 weeks gestation
 
 - Bleeding in first 24 hours after taking Misoprostol
- Light bleeding may be offered reassurance
 - Heavy bleeding (e.g. 2 large soaked pads in 2 hours)
- Take a second dose Misoprostol 800 mcg (or Ibuprofen 800 mg orally once if not available)
 - If heavy bleeding persists >1 hour, patient should be seen in the Emergency Department (or office)
 - If bleeding decreases, patient should have follow-up within 1 week
 
 
 - Spotting periodically for 2 to 3 weeks after taking Misoprostol
- Otherwise asymptomatic patients may be offered reassurance
 
 - Persistent bleeding (more than spotting) for >1 month after taking Misoprostol
- Non-orthostatic patients with normal Hemoglobin
- Consider repeat Misoprostol 800 mcg dose
 - Iron Supplementation as needed
 
 - Less reassuring findings (e.g. Orthostasis, significant Anemia)
- See Postabortion Hemorrhage
 - Pelvic Ultrasound
 - Consider Suction Dilation and Curettage
 
 
 - Non-orthostatic patients with normal Hemoglobin
 
 - Background
 - Red Flag findings prompting medical evaluation after self-medicated termination
- See bleeding management as above
 - Severe, unrelenting Pelvic Pain
- Patients should expect pelvic cramping that is more intense than a typical menstrual period
 
 - Severe persistent Nausea and Vomiting (e.g. failed termination)
 - Fever (e.g. Endometritis, Septic Abortion)
 
 - References
 
VIII. Resources
- Comprehensive Options Counseling (Provider education)
 - All-Options Counseling (patient and provider education)
 - Pregnancy Options Counseling (ACOG, Patient Education)
 
IX. Prevention
- See Contraception
 
X. References
- (2014) Obstet Gynecol 123(3): 676-92 [PubMed]
 - Finer (2014) Am J Public Health 104(suppl 1): S43-8 [PubMed]
 - MacNaughton (2021) Am Fam Physician 103(8) 473-80 [PubMed]
 - Moss (2015) Am Fam Physician 91(8): 544-9 [PubMed]
 - Valerio (2025) Am Fam Physician 111(4): 352-60 [PubMed]
 - Wildschut (2011) Cochrane Database Syst Rev (1): CD005216 [PubMed]